HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
HotSpot Therapeutics has raised $100.0M in total funding. The most recent round was Series C. The last funding was announced in November 2021.
HotSpot Therapeutics's investors include B Capital, SR One, Sofinnova Partners, Pivotal bioVenture Partners, Pavilion Capital.
HotSpot Therapeutics is headquartered in Boston, United States.
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
HotSpot Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HotSpot Therapeutics — Funding & Investors." VCBacked, November 29, 2021, https://www.vcbacked.co/company/hotspot-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). HotSpot Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/hotspot-therapeutics
{{cite web |title=HotSpot Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hotspot-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated